Skip to main content
Mayo Clinic Proceedings: Digital Health logoLink to Mayo Clinic Proceedings: Digital Health
. 2024 May 21;2(2):270–279. doi: 10.1016/j.mcpdig.2024.03.007

A Systematic Review of Natural Language Processing Methods and Applications in Thyroidology

Ricardo Loor-Torres a, Mayra Duran a, David Toro-Tobon b, Maria Mateo Chavez a, Oscar Ponce d, Cristian Soto Jacome a, Danny Segura Torres a,d,h, Sandra Algarin Perneth a, Victor Montori a, Elizabeth Golembiewski a, Mariana Borras Osorio a, Jungwei W Fan e, Naykky Singh Ospina c,f, Yonghui Wu g, Juan P Brito a,b,
PMCID: PMC11210322  NIHMSID: NIHMS2002602  PMID: 38938930

Abstract

This study aimed to review the application of natural language processing (NLP) in thyroid-related conditions and to summarize current challenges and potential future directions. We performed a systematic search of databases for studies describing NLP applications in thyroid conditions published in English between January 1, 2012 and November 4, 2022. In addition, we used a snowballing technique to identify studies missed in the initial search or published after our search timeline until April 1, 2023. For included studies, we extracted the NLP method (eg, rule-based, machine learning, deep learning, or hybrid), NLP application (eg, identification, classification, and automation), thyroid condition (eg, thyroid cancer, thyroid nodule, and functional or autoimmune disease), data source (eg, electronic health records, health forums, medical literature databases, or genomic databases), performance metrics, and stages of development. We identified 24 eligible NLP studies focusing on thyroid-related conditions. Deep learning-based methods were the most common (38%), followed by rule-based (21%), and traditional machine learning (21%) methods. Thyroid nodules (54%) and thyroid cancer (29%) were the primary conditions under investigation. Electronic health records were the dominant data source (17/24, 71%), with imaging reports being the most frequently used (15/17, 88%). There is increasing interest in NLP applications for thyroid-related studies, mostly addressing thyroid nodules and using deep learning-based methodologies with limited external validation. However, none of the reviewed NLP applications have reached clinical practice. Several limitations, including inconsistent clinical documentation and model portability, need to be addressed to promote the evaluation and implementation of NLP applications to support patient care in thyroidology.


Article Highlights.

  • NLP has the potential to streamline healthcare data retrieval, reducing laborious tasks for stakeholders.

  • Despite its promising applications in research and patient care, our review revealed limited NLP exploration in thyroidology.

  • The most investigated domain was thyroid nodules, primarily using electronic health records with radiology reports as the primary data source.

  • Traditional challenges in NLP exploration and implementation include language diversity, contextual comprehension, and model portability.

  • Large language models have been recently explored and offer solutions to previously NLP encountered challenges.

Artificial intelligence (AI) aims to achieve human-like intelligence through entities (eg, machines), capable of processing and performing actions akin to human behavior.1 In addition, machine learning stands as a rapidly evolving field of computer science that seeks to train machines using data sets to perform time-consuming tasks that typically require human cognitive abilities. Its potential to solve real-world challenges across various domains, including health care, has led to increased research into its uses.2 By integrating different AI modalities into the decision-making process of physicians, this technology has the potential to enhance the field of medicine by improving the accuracy of diagnostic tests, streamlining provider workflow, enabling better disease and therapeutic monitoring, and resulting in better patient outcomes.3,4

Natural language processing (NLP) represents the intersection between linguistics and AI, analyzing text and speech to achieve human-like language understanding.5 Despite its more than 50-year history, the growing applicability in medicine has sparked significant interest in these technologies, particularly by overcoming previous limitations through advancements in machine and deep learning.5,6 In health care, NLP models have primarily been used to identify and extract information from unstructured data from the electronic health records (EHRs).7 The implementation of EHRs has led to exponential growth in the volume of health care data over the past 2 decades. However, only around 20% of EHR data are estimated to be structured as diagnostic or billing codes and simple clinical variables like vital signs or laboratory results. In contrast, the bulk of data in EHRs are unstructured in free text, like clinical notes or diagnostic reports, making their use in research time-consuming and challenging.8 To address this challenge, NLP techniques have been developed to efficiently extract and standardize diverse medical data from textual sources, encompassing elements like history and physical examinations, laboratory findings, diagnostic reports, and treatment records.9 For example, in radiology, NLP has been used to identify specific features of interest within imaging reports.10 Similarly, in the field of oncology, it has been leveraged to extract and categorize information from pathology reports, thereby supporting the staging and prediction of outcomes for various types of cancer.11

Thyroid disorders are highly prevalent among the general population. Recent studies have demonstrated the effectiveness of various NLP systems in extracting relevant information from EHRs within the field of thyroidology.12 These NLP-driven approaches have shown promise in enhancing and validating diagnostic and prognostic tools for various thyroid pathologies, including functional thyroid disorders, thyroid nodules, and thyroid cancer.4,13 Despite these promising developments, the existing literature lacks a comprehensive overview. Such an overview could prove invaluable for clinicians, researchers, and other stakeholders interested in understanding how NLP can be applied to improve the care of patients with thyroid diseases. This study was designed to fill this gap by systematically reviewing the applications of NLP in thyroid-related conditions. We also aimed to summarize the current challenges and provide insights into future perspectives in this burgeoning field.

Methods

This systematic review was conducted based on a priori established protocol, available in PROSPERO (CRD42022375085). This article is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA).14

Data Sources and Search Strategy

A comprehensive search was conducted in multiple scientific databases for articles published between January 2012 and November 2022. Databases included Ovid MEDLINE, Epub Ahead of Print, In-Process & Other Non-Indexed Citations; Daily; Ovid EMBASE; Ovid Cochrane Central Register of Controlled Trials; Ovid Cochrane Database of Systematic Reviews; and Scopus. The search strategy for references using NLP in patients with thyroid conditions was designed and conducted by an experienced librarian (L.P.). Subsequently, a snowballing technique was applied to expand our search by identifying additional potentially relevant references that might have been overlooked during the initial search or published after our search timeline, until April 2023. The full search strategy is described in Supplemental Material (available online at https://www.mcpdigitalhealth.org/).

Eligibility Criteria

We included studies describing empirical research about the application of NLP methods for any thyroid-related condition. Studies were excluded for the following reasons: nonempirical works, such as editorials, systematic reviews, and commentaries; not performed in humans; or not published or available in English. In cases of multiple studies by the same research group using the same data set, we prioritized based on the publication date (including the most recent and excluding the earlier ones).

Study Selection Process

All titles, abstracts, and full texts were independently screened using standardized and piloted criteria through the Distiller Systematic Review software by pairs of reviewers (D.S.T., C.S.J., M.D., and R.L.-T.). For each stage, we conducted pilots to calibrate judgments among the reviewers. Disagreements between 2 reviewers were resolved by consensus.

Data Collection and Analyses

For all included studies, we extracted the following variables: general study characteristics, including year, country, and population demographic characteristics; and NLP applications or tasks (eg, identification, classification, or automation). Notably, certain publications involved multiple NLP applications, which were categorized accordingly. Furthermore, we noted the thyroid conditions (eg, thyroid cancer, thyroid nodule, or functional or autoimmune disease), data source (eg, EHR, online health forums or social media, medical literature databases, or genomic databases), evaluated data set, applied NLP methods (eg, rule-based, machine learning, deep learning, or hybrid), performance metrics (eg, accuracy, sensitivity [SN], and positive predictive value [PPV]), and stages of development of the models (eg, training, validation, or testing). In cases in which the data were unavailable, we abstained from extraction.

Results were summarized using frequencies and percentages for categorical variables. The exploratory nature of the research question, the heterogeneity of methodology, and the lack of consensus on the quality assessment approach for the NLP models prevented a quantitative meta-analysis and the evaluation of the risk of bias. Instead, data were analyzed using a meta-narrative approach.15

Results

Study Selection and Characteristics

A total of 2111 potentially relevant references were identified and retrieved through the electronic database search. After screening the titles and abstracts, 2007 studies were excluded. During the subsequent full-text screening, 86 studies were excluded, primarily for either not describing applied NLP methods or not focusing on thyroid conditions. Ultimately, 18 articles met our eligibility criteria and were included in the review. Using the snowballing technique, we identified and added 6 relevant studies to our analysis. Consequently, 24 articles were finally included in our study (Figure 1).

Figure 1.

Figure 1

PRISMA-P flow diagram depicting the study selection process. NLP, natural language processing; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis.

An increasing trend in yearly NLP-based thyroid publications was observed, especially in the past 3 years, with more than half of the included articles falling within this timeframe (15/24, 62.5%). Most studies were conducted in the United States (12/24, 50%), followed by China (7/24, 29%) and South Korea (3/24, 12%). In addition, demographic characteristics were reported in approximately one-third of the studies included (9/24, 37%) (Table).16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38

Table.

Baseline Characteristics of the Studies Analyzed in This Systematic Review

Reference, year Study design Demographic informationa Thyroid condition Data source Cohort AI methods and tasks
Canton et al,16 2021; USA Single center Age, gender, ethnicity Thyroid nodules EHR 2289 records DL
Retrospective Radiology reports Identification
Chen et al,17 2017; China Single center NA Thyroid nodules EHR 13,592 records DL
Retrospective Radiology reports Classification
Chen et al,18 2018; China Single center NA Thyroid nodules EHR 6116 records DL
Retrospective Radiology reports Classification
Chen et al,19 2020; USA Multicenter NA Thyroid nodules EHR 247 records RB
Retrospective Radiology reports Identification, automation
Chen et al,20 2022; China NA NA Thyroid nodules MLD 5770 references ML
Retrospective PubMed Automation
Dedhia et al,21 2022; USA Multicenter NA Thyroid nodules EHR 1612 records Hybrid
Retrospective Radiology reports Identification, automation
Drake et al,22 2019; USA Multicenter Age, gender Thyroid nodules EHR 51,907 records RB
Retrospective Radiology reports Identification
Grani et al,23 2021; Italy NA NA Functional or autoimmune disease SM 27,525 entries ML
Retrospective Medicitalia.it Classification
Kongburan et al,24 2016; Thailand NA NA Thyroid cancer MLD 500 references ML
Retrospective PubMed Automation
Lian et al,25 2023; USA Single center NA Thyroid cancer EHR 500 records DL
Retrospective Interviews 100 patient sample Classification
Luft et al,26 2019; USA Single center Age, gender, ethnicity Functional or autoimmune disease EHR 84,000 records RBb
Retrospective Patient charts 1319 patient sample Identification
Miao et al,27 2020; China Single center Age, gender Thyroid nodules EHR 1290 records NA
Retrospective Radiology and pathology reports Identification
Park and Hong,28 2018; South Korea NA Age, gender Functional or autoimmune disease SM 1768 entries ML
Retrospective WebMD Classification
Park et al,29 2021; South Korea Multicenter Age, gender Thyroid cancer EHR 308 records RB
Retrospective Radiology reports 220 patient sample Automation
Pathak et al,30 2023; USA Multicenter NA Thyroid nodules EHR 490 records DL
Retrospective Radiology reports Identification
Santos et al,31 2021; USA Single center Age, gender, ethnicity Thyroid nodules EHR 1132 records DL
Retrospective and prospective Radiology reports Identification, automation
Short et al,32 2022; USA Single center Age, gender, ethnicity, comorbidities Thyroid nodules EHR 13,385 records DL
Retrospective Radiology reports Identification, automation
Yoo et al,12 2022; South Korea Multicenter Age, gender Thyroid cancer EHR 108,372 records RB
Retrospective Radiology and pathology reports Classification
Zhang et al,33 2021; China NA NA Thyroid cancer MLD 34,692 references ML
Retrospective PubMed Automation
Zhang et al,34 2022; China Multicenter NA Thyroid cancer EHR 788,129 records DL
Retrospective Radiology reports Automation
Zhang et al,35 2023; USA Multicenter NA Thyroid nodules EHR 565 records Hybrid
Retrospective Radiology and pathology reports 471 patient sample Identification, automation
Zheng et al,36 2020; USA NA NA Functional or autoimmune disease GD 772,394 records NA
Retrospective BioVU DNA biobank 84,821 patient sample Identification
Zhou et al,37 2021; USA NA NA Thyroid cancer GD NA NA
Retrospective ClinGen, NCCN guidelines, OMIM, Genetics Home Reference, GeneCards, and Gene-NCBI Automation
Zou et al,38 2021; China Single center NA Thyroid nodules EHR 5328 records DL
Retrospective Radiology reports Classification

DL, deep learning; EHR, electronic health records; GD, genetic database; ML, machine learning; MLD, medical literature database; NA, not applicable or reported; RB, ruled-based; SM, social media.

a

Analysis from studies in which demographic information from data sets were reported.

b

Not specified, however presumed to be the most likely implemented method.

Data Sources

Most studies included EHR as the retrieved source (17/24, 71%), followed by medical literature databases (3/24, 13%) such as PubMed, genomic databases (2/24, 8%), and online health forums or social media (2/24, 8%) (Figure 2). Within the studies that used data from EHRs, radiologic reports emerged as the most used source, constituting 88% (15/17) of the cases. Among these, thyroid ultrasound data were the prevailing imaging modality, used in 73% (11/15) of instances, while computer tomography scan reports were used in 20% (3/15) of cases. Three studies used both radiology and pathology reports.12,27,35 The studies were presented with varying data set sizes. Of the 24 studies, 11 (45%) used sample sizes of less than 5000 records, and 9 of 24 (38%) studies used data sets with more than 10,000 records.

Figure 2.

Figure 2

Sankey flow diagram depicting the distribution of thyroid. DL, deep learning; EHR, electronic health records; F or AD, functional and autoimmune disease; GD, genetic database; ML, machine learning; MLD, medical literature database; NA, not applicable or reported; RB, ruled-based; SM, social media.

NLP Application in Thyroid Conditions

We found that thyroid nodule was the most investigated domain (13/24, 54%), followed by thyroid cancer (7/24, 29%), and functional and autoimmune disease (4/24, 17%). Supplemental Table 1 (available online at https://www.mcpdigitalhealth.org/) describes an in-depth analysis of the NLP methods used on various data sources to achieve distinct tasks within the thyroid conditions Supplemental Table 2.

NLP Applications in Thyroid Nodules

Several NLP algorithms were developed and trained on large data sets to classify nodules as benign or malignant based on reported radiologic features (accuracy, 86%-88%; SN, 84%-92%; and PPV, 94%).18,38 In addition, other NLP models aimed at identifying granular radiology characteristics from ultrasound reports (accuracy, 77%-98%; SN, 85%-98%; and PPV:,74%-98%).21,30,31

Incidental thyroid findings are often observed in nonthyroid-related images, leading to increased detection of nodules and a potential thyroid cancer diagnosis. Drake et al22 used an NLP algorithm to evaluate the prevalence of incidental findings across various imaging modalities. In addition, Canton et al16 developed a highly accurate model for detecting thyroid lesions in imaging studies frequently used during trauma assessments in emergency department settings (SN, 90%; specificity, 95.3%).

The Thyroid Imaging, Reporting, and Data System (TI-RADS) is commonly used to ensure consistency in reporting systems for thyroid nodule characteristics.39,40 Chen et al19 developed a model to capture the crucial missing elements of TI-RADS. Moreover, Short et al32 engineered an NLP pipeline tailored to identify radiologic reports that align with the criteria for follow-up assessments. Their model exhibited promising accuracy (96.5%), SN (92.1%), and specificity (96%). Furthermore, Santos et al31 introduced a model designed to integrate TI-RADS reports with patient demographic information and comorbidities. Significantly, this model underwent prospective validation (accuracy, 0.89; F1 score, 0.99) and testing at an external facility (accuracy, 0.85; F1 score, 0.94).31 Finally, Zhang et al35 crafted a multistep model capable of integrating data from thyroid images, pathology reports, and radiology reports, achieving a commendable accuracy rate of 83%.

NLP Applications in Thyroid Cancer

Lian et al25 developed an NLP pipeline to measure and categorize health-related quality of life based on narrative interviews with patients who underwent surgical treatment (area under the curve, 0.76; accuracy, 70.09; SN, 70.02%; and PPV, 70.20%).25 In addition, Yoo et al12 developed an NLP algorithm to determine thyroid cancer diagnosis and stage based on retrospective information from medical records, specifically using surgical pathology and whole-body scan reports (SN, 100%; PPV, 100%). Another application was able to retrieve information from online publications and genomic databases to identify genes contributing to nonmedullary thyroid cancer, encompassing 95%-97% of all thyroid cancers. The study by Zhou et al37 used an NLP algorithm to identify nonmedullary thyroid cancer–related genes from online databases.

NLP Applications in Functional and Autoimmune Disease

Grani et al23 used an NLP pipeline to collect data from text messages in an online open medical forum to analyze patient experiences of living with hypothyroidism and concerns regarding their medication. Similarly, Park and Hong28 aimed to uncover patients’ perspectives on thyroid hormone replacement therapy from online health forums (WebMD) and determine its impact on treatment satisfaction. In another study, Zheng et al36 developed an NLP-based tool, capable of extracting clinical characteristics of patients with hypothyroidism from EHRs based on phenotypes collected from an array of medical resources, with an accuracy rate of over 97%.36 Finally, Luft et al26 used NLP to extract clinical features from EHRs from a cohort of pediatric patients with mood and anxiety disorders and correlated them with abnormal thyroid stimulating hormone levels.

Discussion

The digitalization of health care has aimed to improve patient care, streamline health care processes, and revolutionize clinical and health care delivery research.41 NLP can retrieve large volumes of narrative data and transform it into computable elements for downstream analyses, which was previously limited by labor-intensive and time-consuming manual extraction by human annotators.42 As in every area of health care, the potential applications and benefits of NLP in thyroid diseases are enormous. For instance, we noted an increasing number of NLP-based thyroid publications, especially in the past 3 years, with more than half of the included articles falling within this timeframe. To our knowledge, this is the first systematic review of NLP applications in the context of thyroidology. Our systematic review identified that, although still limited, NLP is already being used to study thyroid diseases, particularly thyroid nodules, and thyroid cancer, which were the focus of 54% and 29% of the studies included in our review, respectively.

Studies have applied NLP to extract thyroid nodule features from radiology reports leveraging state-of-the-art deep learning models.30 Furthermore, although some models focused on basic tasks, such as detecting the presence of thyroid incidentalomas in computed tomography, magnetic resonance imaging, or ultrasound reports,16,22 more sophisticated models were capable of determining whether the reported incidentaloma met the criteria for further ultrasound evaluation and additionally tracked the completion of such evaluations.32 Compared with traditional manual extraction of unstructured data, these models effectively harnessed large volumes of data, facilitating observational research, promoting quality improvement initiatives, enabling standardization of unstructured documentation, and developing real-time predictive tools for clinical care. In addition, NLP models were able to build large-volume data sets by extracting features from different free text sources, including diagnostic and pathology reports and clinician documentation.12,21 Furthermore, some models standardized unstructured data from multiple institutions to generate multicenter data sets.12,19,21,29,34

Although most models used EHR data, other valuable data sources have been explored. Zheng et al36 used NLP-extracted phenotypes from several online resources. Others used NLP tools to facilitate abstract screening for systematic literature reviews on thyroid cancer genetic associations or even automatically analyzing and integrating findings from previously published literature.24 These initiatives allowed the researchers to use data more efficiently and comprehensively from the exponentially growing body of literature and genetic repositories. In addition, Park and Hong28 used NLP on social media posts to identify issues related to thyroid hormone replacement from patient medication reviews. This type of tool can provide a more complete picture of the patient experience, including their emotional and social responses to their condition and treatments, which might not be efficiently captured in clinical records, to facilitate the identification of themes for discussion during shared decision-making encounters and characterize elements to be considered on future treatment or quality-of-life studies.

Notwithstanding the promising results of NLP, none of the applications included in this review are readily available for use in clinical practice. Notably, among the 24 studies identified, only 1 adopted a prospective design,31 and 2 undertook validation of their NLP models in an external health care setting.31,34 The road to incorporating these NLP interventions into routine research or clinical practice is riddled with several challenges that need careful consideration and concerted efforts to surmount. Specifically in the thyroid field, we hypothesize that the uptake of NLP methods is associated with the complexity of the thyroid-related domains, variations in language expression and reporting styles, completeness and accuracy of clinical documentation (ie, data on patient-specific concerns, complaints, or severity of symptoms depends on the accuracy of providers’ documentation), semantic (ie, misspellings, abbreviations, acronyms, or synonyms), and context (ie, it is challenging to create algorithms that can appropriately extract chronologic descriptions or simultaneous references in situations like a thyroid ultrasound report that includes several nodules), which can affect the NLP outcome, decrease the performance of the algorithm when applied to different institutions, and limit the portability and scalability of the interventions.7,21,34,43 In addition, data sources need to be representative of the population to avoid the incorporation of inequities and social bias into the models.44 Finally, using NLP methods requires high optimization for the local environment and extensive domain knowledge, which can be expensive, and stakeholders’ lack of financial resources or prioritization could halt their implementation. Thus, efficacy and cost-effectiveness trials are important to demonstrate the value of the intervention and facilitate its adoption.41

The examination of NLP studies within the domain of thyroidology, as presented in this review, has brought to light a pronounced divergence in NLP methods. Deep learning emerged as the preferred NLP method, with some studies applying pretrained large language models,16,25,30,34 followed by rule-based approaches. However, it is noteworthy that some studies refrained from providing explicit specifications regarding the used NLP methods.

In contemplating the future of NLP within the domain of thyroid nodule and cancer management, it is evident that enhancing the reporting system methods and integrating models, particularly with the framework of large language models, will significantly expand the role of NLP. This integration marks a shift toward more sophisticated, efficient, and versatile applications of NLP in thyroid nodule and cancer management.

We acknowledge several limitations that should be considered when evaluating our results. The heterogeneity observed in methodology, outcomes, and performance metrics across the included studies made it unfeasible to consistently report the results of the individual studies and to conduct a meta-analysis. In addition, we must recognize the potential for publication bias, which could lead to an overrepresentation of favorable results. However, despite these limitations, it is crucial to highlight the strengths of our systematic review. We adhered diligently to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines, ensuring a methodical and standardized approach to our review process. Furthermore, we successfully identified many publications that met our rigorous inclusion criteria. Consequently, our findings provide a comprehensive and robust characterization of the current landscape of NLP in thyroidology, holding valuable implications for clinicians, researchers, and other stakeholders invested in this field of study.

Conclusion

The utilization of NLP within the realm of thyroidology exhibits a growing interest and holds the potential for advancing both research and patient care, while mitigating the burden placed on healthcare system stakeholders. However, it is noteworthy that the domains of interest within thyroidology and the NLP methodologies used remain somewhat restricted. Consequently, ample opportunity exists for further exploration, encompassing the untapped potential of NLP applications in various thyroid conditions that have yet to be investigated.

Potential Competing Interests

Drs Brito and Soto Jacome were supported by the National Cancer Institute of the National Institutes of Health under Award Number R37CA272473. N.S.O. was supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA248972. Dr Wu was supported by Patient-Centered Outcomes Research Institute (PCORI) under Award Number ME-2018C3-14754 and National Institute on Aging under Award Number R56AG069880. The other authors report no competing interests.

Acknowledgments

Drs Loor-Torres and Duran contributed equally to this work. We thank Larry Prokop, MLS, for the invaluable support and enhancement of our search strategy throughout the systematic review.

Footnotes

Grant Support: This work was supported by the National Cancer Institute of the National Institutes of Health under award Number R37CA272473 (J.P.B. and C.S.J.) and award number K08CA248972 (N.S.O.) and by Patient-Centered Outcomes Research Institute (PCORI) under award number ME-2018C3-14754 (Y.W.) and National Institute on Aging under award number R56AG069880 (Y.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the PCORI and National Institutes of Health.

Supplemental material can be found online at https://www.mcpdigitalhealth.org/. Supplemental material attached to journal articles has not been edited, and the authors take responsibility for the accuracy of all data.

Supplemental Online Material

Supplemental Table 1
mmc1.pdf (152.3KB, pdf)
Supplemental Table 2
mmc2.pdf (79.2KB, pdf)
Supplemental Material
mmc3.pdf (84KB, pdf)
Supplemental Data
mmc4.pdf (68.1KB, pdf)

References

  • 1.Sarker I.H. AI-based modeling: techniques, applications and research issues towards automation, intelligent and smart systems. SN Comput Sci. 2022;3(2):158. doi: 10.1007/s42979-022-01043-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Silva G.F.S., Fagundes T.P., Teixeira B.C., Chiavegatto Filho A.D.P. Machine learning for hypertension prediction: a systematic review. Curr Hypertens Rep. 2022;24(11):523–533. doi: 10.1007/s11906-022-01212-6. [DOI] [PubMed] [Google Scholar]
  • 3.Kaul V., Enslin S., Gross S.A. History of artificial intelligence in medicine. Gastrointest Endosc. 2020;92(4):807–812. doi: 10.1016/j.gie.2020.06.040. [DOI] [PubMed] [Google Scholar]
  • 4.Toro-Tobon D., Loor-Torres R., Duran M., et al. Artificial intelligence in thyroidology: a narrative review of the current applications, associated challenges, and future directions. Thyroid. 2023;33(8):903–917. doi: 10.1089/thy.2023.0132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nadkarni P.M., Ohno-Machado L., Chapman W.W. Natural language processing: an introduction. J Am Med Inform Assoc. 2011;18(5):544–551. doi: 10.1136/amiajnl-2011-000464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Esteva A., Robicquet A., Ramsundar B., et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24–29. doi: 10.1038/s41591-018-0316-z. [DOI] [PubMed] [Google Scholar]
  • 7.Hossain E., Rana R., Higgins N., et al. Natural language processing in electronic health records in relation to healthcare decision-making: a systematic review. Comput Biol Med. 2023;155 doi: 10.1016/j.compbiomed.2023.106649. [DOI] [PubMed] [Google Scholar]
  • 8.HIT Consultant Why unstructured data holds the key to intelligent healthcare systems. https://hitconsultant.net/2015/03/31/tapping-unstructured-data-healthcares-biggest-hurdle-realized/
  • 9.Demner-Fushman D., Chapman W.W., McDonald C.J. What can natural language processing do for clinical decision support? J Biomed Inform. 2009;42(5):760–772. doi: 10.1016/j.jbi.2009.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mithun S., Jha A.K., Sherkhane U.B., et al. Clinical concept-based radiology reports classification pipeline for lung carcinoma. J Digit Imaging. 2023;36(3):812–826. doi: 10.1007/s10278-023-00787-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yim W.W., Yetisgen M., Harris W.P., Kwan S.W. Natural language processing in oncology: a review. JAMA Oncol. 2016;2(6):797–804. doi: 10.1001/jamaoncol.2016.0213. [DOI] [PubMed] [Google Scholar]
  • 12.Yoo S., Yoon E., Boo D., et al. Transforming thyroid cancer diagnosis and staging information from unstructured reports to the observational medical outcome partnership common data model. Appl Clin Inform. 2022;13(3):521–531. doi: 10.1055/s-0042-1748144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Idarraga A.J., Luong G., Hsiao V., Schneider D.F. False negative rates in benign thyroid nodule diagnosis: machine learning for detecting malignancy. J Surg Res. 2021;268:562–569. doi: 10.1016/j.jss.2021.06.076. [DOI] [PubMed] [Google Scholar]
  • 14.Shamseer L., Moher D., Clarke M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350 doi: 10.1136/bmj.g7647. [DOI] [PubMed] [Google Scholar]
  • 15.Greenhalgh T., Robert G., Macfarlane F., Bate P., Kyriakidou O., Peacock R. Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Soc Sci Med. 2005;61(2):417–430. doi: 10.1016/j.socscimed.2004.12.001. [DOI] [PubMed] [Google Scholar]
  • 16.Canton S.P., Dadashzadeh E., Yip L., Forsythe R., Handzel R. Automatic detection of thyroid and adrenal incidentals using radiology reports and deep learning. J Surg Res. 2021;266:192–200. doi: 10.1016/j.jss.2021.03.060. [DOI] [PubMed] [Google Scholar]
  • 17.Chen D., Shi C., Wang M., Pan Q. Neural Information Processing; 24th International Conference, ICONIP 2017, Guangzhou, China, November 14-18, 2017, Proceedings, Part V 24. Springer; 2017. Thyroid nodule classification using hierarchical recurrent neural network with multiple ultrasound reports; pp. 765–773. [Google Scholar]
  • 18.Chen D., Zhang J., Li W. 2018 9th International Conference on Information Technology in Medicine and Education (ITME) IEEE; 2018. Thyroid nodule classification using two levels attention-based bi-directional LSTM with ultrasound reports. [DOI] [Google Scholar]
  • 19.Chen K.J., Dedhia P.H., Imbus J.R., Schneider D.F. Thyroid ultrasound reports: will the thyroid imaging, reporting, and data system improve natural language processing capture of critical thyroid nodule features? J Surg Res. 2020;256:557–563. doi: 10.1016/j.jss.2020.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chen P., Feng C., Huang L., Chen H., Feng Y., Chang S. Exploring the research landscape of the past, present, and future of thyroid nodules. Front Med (Lausanne) 2022;9 doi: 10.3389/fmed.2022.831346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dedhia P.H., Chen K., Song Y., et al. Ambiguous and incomplete: natural language processing reveals problematic reporting styles in thyroid ultrasound reports. Methods Inf Med. 2022;61(1-2):11–18. doi: 10.1055/s-0041-1740493. [DOI] [PubMed] [Google Scholar]
  • 22.Drake T., Gravely A., Westanmo A., Billington C. Prevalence of thyroid incidentalomas from 1995 to 2016: a single-center, retrospective cohort study. J Endocr Soc. 2020;4(1) doi: 10.1210/jendso/bvz027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Grani G., Lenzi A., Velardi P. Supporting personalized health care with social media analytics: an application to hypothyroidism. ACM Trans Comput Healthcare. 2022;3(1):1–28. doi: 10.1145/3468781. [DOI] [Google Scholar]
  • 24.Kongburan W., Padungweang P., Krathu W., Chan J.H. 2016 Eighth International Conference on Advanced Computational Intelligence (ICACI) IEEE; 2016. Semi-automatic construction of thyroid cancer intervention corpus from biomedical abstracts; pp. 150–157. [Google Scholar]
  • 25.Lian R., Hsiao V., Hwang J., et al. Predicting health-related quality of life change using natural language processing in thyroid cancer. Intell Based Med. 2023;7 doi: 10.1016/j.ibmed.2023.100097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Luft M.J., Aldrich S.L., Poweleit E., et al. Thyroid function screening in children and adolescents with mood and anxiety disorders. J Clin Psychiatry. 2019;80(5) doi: 10.4088/JCP.18m12626. [DOI] [PubMed] [Google Scholar]
  • 27.Miao S., Jing M., Sheng R., et al. The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports. Gland Surg. 2020;9(3):653–660. doi: 10.21037/gs.2020.04.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Park S.H., Hong S.H. Identification of primary medication concerns regarding thyroid hormone replacement therapy from online patient medication reviews: text mining of social network data. J Med Internet Res. 2018;20(10) doi: 10.2196/11085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Park J., You S.C., Jeong E., et al. A framework (SOCRATex) for hierarchical annotation of unstructured electronic health records and integration into a standardized medical database: development and usability study. JMIR Med Inform. 2021;9(3) doi: 10.2196/23983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pathak A., Yu Z., Paredes D., et al. Extracting thyroid nodules characteristics from ultrasound reports using transformer-based natural language processing methods. AMIA Annu Symp Proc. 2023:1193–1200. doi: 10.48550/arXiv.2304.0011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Santos T., Kallas O.N., Newsome J., Rubin D., Gichoya J.W., Banerjee I. Vol. 2021. AMIA Annu Symp Proc.; 2021. A fusion NLP model for the inference of standardized thyroid nodule malignancy scores from radiology report text; pp. 1079–1088. [PMC free article] [PubMed] [Google Scholar]
  • 32.Short R.G., Dondlinger S., Wildman-Tobriner B. Management of incidental thyroid nodules on chest CT: using natural language processing to assess white paper adherence and track patient outcomes. Acad Radiol. 2022;29(3):e18–e24. doi: 10.1016/j.acra.2021.02.019. [DOI] [PubMed] [Google Scholar]
  • 33.Zhang Z., Yao L., Wang W., Jiang B., Xia F., Li X. A bibliometric analysis of 34,692 publications on thyroid cancer by machine learning: how much has been done in the past three decades? Front Oncol. 2021;11 doi: 10.3389/fonc.2021.673733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zhang Q., Zhang S., Li J., et al. Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study. Cancer Biol Med. 2021;19(5):733–741. doi: 10.20892/j.issn.2095-3941.2020.0509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhang J., Mazurowski M.A., Allen B.C., Wildman-Tobriner B. Multistep Automated Data Labelling Procedure (MADLaP) for thyroid nodules on ultrasound: an artificial intelligence approach for automating image annotation. Artif Intell Med. 2023;141 doi: 10.1016/j.artmed.2023.102553. [DOI] [PubMed] [Google Scholar]
  • 36.Zheng N.S., Feng Q., Kerchberger V.E., et al. PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health records. J Am Med Inform Assoc. 2020;27(11):1675–1687. doi: 10.1093/jamia/ocaa104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhou J., Singh P., Yin K., et al. Non-medullary thyroid cancer susceptibility genes: evidence and disease spectrum. Ann Surg Oncol. 2021;28(11):6590–6600. doi: 10.1245/s10434-021-09745-x. [DOI] [PubMed] [Google Scholar]
  • 38.Zuo M., Zhao H., Huang M., Chen D. 2021 IEEE International Conference on Dependable, Autonomic and Secure Computing, International Conference on Pervasive Intelligence and Computing, International Conference on Cloud and Big Data Computing, International Conference on Cyber Science and Technology Congress (DASC/PiCom/CBDCom/CyberSciTech) IEEE; 2021. Knowledge-Powered Thyroid Nodule Classification with Thyroid Ultrasound Reports; pp. 597–604. [DOI] [Google Scholar]
  • 39.Tessler F.N., Middleton W.D., Grant E.G., et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–595. doi: 10.1016/j.jacr.2017.01.046. [DOI] [PubMed] [Google Scholar]
  • 40.Horvath E., Majlis S., Rossi R., et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94(5):1748–1751. doi: 10.1210/jc.2008-1724. [DOI] [PubMed] [Google Scholar]
  • 41.Sharma A., Harrington R.A., McClellan M.B., et al. Using digital health technology to better generate evidence and deliver evidence-based care. J Am Coll Cardiol. 2018;71(23):2680–2690. doi: 10.1016/j.jacc.2018.03.523. [DOI] [PubMed] [Google Scholar]
  • 42.Kim E., Rubinstein S.M., Nead K.T., Wojcieszynski A.P., Gabriel P.E., Warner J.L. The evolving use of electronic health records (EHR) for research. Semin Radiat Oncol. 2019;29(4):354–361. doi: 10.1016/j.semradonc.2019.05.010. [DOI] [PubMed] [Google Scholar]
  • 43.Yang L.W.Y., Ng W.Y., Foo L.L., et al. Deep learning-based natural language processing in ophthalmology: applications, challenges and future directions. Curr Opin Ophthalmol. 2021;32(5):397–405. doi: 10.1097/ICU.0000000000000789. [DOI] [PubMed] [Google Scholar]
  • 44.Newman-Griffis D.R., Hurwitz M.B., McKernan G.P., Houtrow A.J., Dicianno B.E. A roadmap to reduce information inequities in disability with digital health and natural language processing. PLoS Digit Health. 2022;1(11) doi: 10.1371/journal.pdig.0000135. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Table 1
mmc1.pdf (152.3KB, pdf)
Supplemental Table 2
mmc2.pdf (79.2KB, pdf)
Supplemental Material
mmc3.pdf (84KB, pdf)
Supplemental Data
mmc4.pdf (68.1KB, pdf)

Articles from Mayo Clinic Proceedings: Digital Health are provided here courtesy of Elsevier

RESOURCES